Modified Porro’s Operation in Ovarian Cancer: a Clinical Case
https://doi.org/10.24060/2076-3093-2021-11-1-41-45
Abstract
Background. Ovarian cancer in pregnancy is quite rare having a top 5th incidence among other pregnancy-associated tumours [1]. Due to a low population rate in pregnant women, the lack of standardised management of such patients and the paucity of relevant randomised and cohort studies, analyses of individual clinical cases acquire particular importance.
Materials and methods. This article presents a clinical case of de novo diagnosed ovarian cancer in pregnancy tackled with a modified Porro’s operation of peritonectomy, para-aortic and parametric lymphadenectomy and greater omentum resection at a gynaecology unit of the Kuvatov Republican Clinical Hospital of Ufa.
Results and discussion. This clinical case is special in terms of a rare occurrence of ovarian cancer in pregnancy. The choice of this radical surgical technique is considered optimal for inspecting most plausible metastatic foci and ensuring a life-preserving prognosis.
Conclusion. In the absence of standardised management protocols in pregnancy-associated ovarian cancer, further analyses and discussions of routine clinical case evidence are imperative.
About the Authors
A. G. Yashchuk
Bashkir State Medical University
Russian Federation
Russian Federation
Alfiya G. Yashchuk — Dr. Sci. (Med.), Prof., Department of Obstetrics and Gynecology with a course of Advanced Professional Education
Ufa
I. B. Fatkullina
Bashkir State Medical University
Russian Federation
Russian Federation
Irina B. Fatkullina — Dr. Sci. (Med.), Prof., Department of Obstetrics and Gynecology with a course of Advanced Professional Education
Ufa
I. R. Rahmatullina
Bashkir State Medical University
Russian Federation
Russian Federation
Irina R. Rakhmatullina — Dr. Sci. (Med.), Prof., Department of Oncology with Courses of Oncology and Pathological Anatomy for Advanced Professional Education
Ufa
I. I. Musin
Bashkir State Medical University
Russian Federation
Russian Federation
Ilnur I. Musin — Cand. Sci. (Med.), Assoc. Prof., Department of Obstetrics and Gynecology with a course of Advanced Professional Education
Ufa
A. R. Molokanova
Bashkir State Medical University
Russian Federation
Russian Federation
Anzhella R. Molokanova — Department of Obstetrics and Gynecology with a course of Advanced Professional Education
Ufa
References
1. Dobrokhotova Yu.E., Payanidi Yu.G., Borovkova E.I., Morozova K.V., Nagaytseva E.A., Arutyunyan A.M. Malignant ovarian tumors in pregnant women. Russian Medical Journal. 2019;27(6):45–52 (In Russ.).
2. Pajanidi Yu.G., Zhordania K.I., Khokhlova S.V., Dobrohotova Yu.E., Shevchuk A.S. Ovarian malignant neoplasms and pregnancy (clinical recommendations ESGO, 2017). Oncogynecology. 2019;1(29):20–7 (In Russ.).
3. Levchenko N.E., Sidorenko Y.S. Ovarian malignant tumors during pregnancy. Oncogynecology. 2017;2(22):46–51 (In Russ.).
4. Limareva S.V. Treatment of malignant tumors in pregnant women (literature review). Oncogynecology. 2017;4(24):66–78 (In Russ.).
5. Blake E.A., Kodama M., Yunokawa M., Ross M.S., Ueda Y., Grubbs B.H., et al. Feto-maternal outcomes of pregnancy complicated by epithelial ovarian cancer: a systematic review of literature. Eur J Obstet Gynecol Reprod Biol. 2015;186:97–105. DOI: 10.1016/j.ejogrb.2015.01.010
6. Zabelin M.V., Safonov A.S., Samorodov A.V., Zolotukhin K.N., Maksyutova A.I. Hemodynamic and metabolic disorders in the hipec treatment of intraperitoneally disseminated ovarian cancer. Healthcare, education and security. 2020;4:7–17 (In Russ.).
7. Gomzikova M.O., Gaifullina R.F., Mustafin I.G., Chernov V.M., Miftahova Z.R., Galyavich AS., et al. Membrane microvesicles: biological properties and involvement in pathogenesis of diseases. Gene and Cells. 2013;8(1):6–11 (In Russ.).
8. Shevljukova T.P., Adeeva O.O., Vzdornova V.G., Samsonov N.S. The course and outcome of pregnancy associated with ovarian cancer. Almanac of Young Science. 2018;4:19–20 (In Russ.).
9. Podlesnaya E.A., Timokhina E.V., Kyurdzhiev S.O., Belousova V.S., Ibragimova S.N. Clinical case of ovarian cystadenocarcinoma during pregnancy. In.: Science, technology and life — 2016: Proceedings of materials the III international scientific conference. Kirov; 2016. P. 432–6.
10. Makacarija N.A. Eduardo Porro. Obstetrics, gynecology and reproduction. 2014;8(3):76–8 (In Russ.).
11. Sidorenko Y.S., Levchenko N.E. Pregnancy and gynecologic cancer. Opinion. Oncogynecology. 2016;1:62–9 (In Russ.).
12. Iqbal J., Kahane A., Park A.L., Huang T., Meschino W.S., Ray J.G. Hormone levels in pregnancy and subsequent risk of maternal breast and ovarian cancer: a systematic review. J Obstet Gynaecol Can. 2019;41(2):217–22. DOI: 10.1016/j.jogc.2018.03.133
13. Payanidi U.G., Zhordania K.I., Dobrohotova U.E., Shevchuk A.S. Borderline ovarian tumors and pregnancy (ESGO Recommendations, 2017). Oncogynecology. 2019;2(30):29–4 (In Russ.).
14. Silkina M.O., Bakhtiyarov K.R. Cancer and pregnancy. Archives of Obstetrics and Gynecology. 2018;5(4):182–6 (In Russ.). DOI: 10.18821/2313-8726-2018-5-4-182-186
15. Dobrokhotova Y.E., Ter-Ovanesov M.D., Danielian S.Z., Venediktova M.G., Sarantsev A.N., Zykov A.E., et al. Clinical case of ovarian cancer during pregnancy. Gynecology. 2016;18(2):84–6 (In Russ.).
16. Nikogosyan S.O., Sekerskaya M.N., Kuznetsov V.V. Possibilities for improvement of the effectiveness of surgical treatment of patients with advanced ovarian cancer. Russian Journal of Oncology. 2018;23(3–6):143–8 (In Russ.). DOI: 10.18821/1028-9984-2018-23-3-4-143-148
17. Ashrafian L.A., Kurtser M.A., Gerasimova A.A., Klimenko P.A. Borderline and malignant ovarian tumors occurred during pregnancy. Oncogynecology. 2019;3(31):68–77 (In Russ.).
Review
For citations:
Yashchuk A.G., Fatkullina I.B., Rahmatullina I.R., Musin I.I., Molokanova A.R. Modified Porro’s Operation in Ovarian Cancer: a Clinical Case. Creative surgery and oncology. 2021;11(1):41-45. (In Russ.) https://doi.org/10.24060/2076-3093-2021-11-1-41-45
Views:
1047
Email this article 